Gravel Pharma Private Limited

Gravel Pharma Private Limited

Founded in 2013 headquartered in Maharashtra, India.
2013 | Latur, Maharashtra (India) | Active

Last Updated:

July 30, 2024
HomeCompanyGravel Pharma Private Limited

Who are the key members and board of directors at Gravel Pharma?

Board Members(4)

NameDesignationAppointment DateStatus
Rahul Laturiya In Director 14-Jun-2013Current
Sanjay Jogdanad In Director 14-Jun-2013Current
Uttam Deshmane In Director 14-Jun-2013Current
Vishnudas Bahndari In Director 14-Jun-2013Current

Financial Performance of Gravel Pharma.

Gravel Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.46% increase. The company also saw a slight improvement in profitability, with a 1.41% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.02%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
2.46%
Revenue from Operations
2.01%
Total Assets
-12.21%
Profit or Loss
1.41%
Net Worth
-20.02%
EBITDA
-2.93%

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Gravel Pharma?

Unlock and access historical data on people associated with Gravel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Gravel Pharma

Recent activity within the organization

  • Annual General Meeting

    Gravel Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Gravel Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

    31 Mar 2023

  • Director Appointment

    Rahul Nandkishor Laturiya was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 11 years 6 months .

    14 Jun 2013

  • Director Appointment

    Sanjay Tukaram Jogdanad was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 11 years 6 months .

    14 Jun 2013

  • Director Appointment

    Uttam Dagdurao Deshmane was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 11 years 6 months .

    14 Jun 2013

  • Director Appointment

    Vishnudas Dwarkadas Bahndari was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 11 years 6 months .

    14 Jun 2013

Frequently asked questions

  • Gravel Pharma Private Limited was incorporated on 14 Jun 2013.

  • The authorized share capital of Gravel Pharma Private Limited is ₹ 2.50 M and paid-up capital is ₹ 0.97 M.

  • Currently 4 directors are associated with Gravel Pharma Private Limited.

    • Rahul Nandkishor Laturiya
    • Sanjay Tukaram Jogdanad
    • Uttam Dagdurao Deshmane
    • Vishnudas Dwarkadas Bahndari
  • As per Ministry of Corporate Affairs (Mca), the registered address of Gravel Pharma Private Limited is Bhakti Nagar Latur Tq. Dist. Latur, Maharashtra, India, 413512.

  • The corporate identification number (CIN) of Gravel Pharma Private Limited is U74999MH2013PTC244491 and the company number is 244491 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Gravel Pharma Private Limited has risen by 2.46%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Gravel Pharma Private Limited has experienced an downturn of -20.02%.

  • The most recent Balance Sheet for Gravel Pharma Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development